Nature Reviews Nephrology

Papers
(The H4-Index of Nature Reviews Nephrology is 63. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Genetics of diabetes mellitus and diabetes complications686
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup445
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19417
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality279
Pathophysiology of COVID-19-associated acute kidney injury278
The current and future landscape of dialysis258
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors252
Autophagy in kidney homeostasis and disease245
Cellular senescence: the good, the bad and the unknown232
The immunology of renal cell carcinoma228
Mitochondrial quality control in kidney injury and repair212
WNT–β-catenin signalling — a versatile player in kidney injury and repair202
Hypertension-induced cognitive impairment: from pathophysiology to public health191
Plant-based diets to manage the risks and complications of chronic kidney disease158
Mental health of health-care workers in the COVID-19 era149
CKD is a key risk factor for COVID-19 mortality145
Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation141
Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection141
Trajectories of kidney function in diabetes: a clinicopathological update137
Determining the true burden of kidney stone disease135
Digital pathology and computational image analysis in nephropathology133
The effect of HIF on metabolism and immunity130
Food as medicine: targeting the uraemic phenotype in chronic kidney disease130
COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19121
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease119
Complexities of the glomerular basement membrane111
Epidemiology of haemodialysis outcomes110
Nitric oxide signalling in kidney regulation and cardiometabolic health110
Cisplatin nephrotoxicity: new insights and therapeutic implications102
Multi-omics integration in the age of million single-cell data102
The fibrogenic niche in kidney fibrosis: components and mechanisms101
COVID-19 vaccination in kidney transplant recipients100
Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative99
Integrated multi-omics approaches to improve classification of chronic kidney disease98
Sustainable Development Goals relevant to kidney health: an update on progress97
Genomic profiling in renal cell carcinoma96
Organ donation and transplantation: a multi-stakeholder call to action95
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects94
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup92
Impact of the COVID-19 pandemic on clinical research92
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function89
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence89
Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation87
COVID-19 vaccines and kidney disease84
COVID-19: implications for immunosuppression in kidney disease and transplantation80
Association of metabolic dysfunction-associated fatty liver disease with kidney disease78
The COVID-19 pandemic: consequences for nephrology77
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury74
Trained immunity — basic concepts and contributions to immunopathology74
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease74
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations74
Role of the cGAS–STING pathway in systemic and organ-specific diseases73
Kidney and heart failure outcomes associated with SGLT2 inhibitor use72
Glomerular hyperfiltration71
Circular RNAs in kidney disease and cancer70
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics69
Patient-centred approaches for the management of unpleasant symptoms in kidney disease69
Health inequities and the inappropriate use of race in nephrology68
Extracellular vesicles in kidney disease68
Therapeutic advances in COVID-1968
Immunopathophysiology of trauma-related acute kidney injury67
Pathogenesis of autoimmune disease64
Kidney dendritic cells: fundamental biology and functional roles in health and disease63
The genetics of kidney stone disease and nephrocalcinosis63
Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus63
Phenotypic diversity and metabolic specialization of renal endothelial cells63
0.048719167709351